英文摘要 |
Aspergillus species are universally present in the environment. Invasive Aspergillus infections usually occur in immunocompromised patients. It has become a serious problem largely due to the growing number of cancer patients who receive chemotherapy or immunotherapy, which prolongs the duration of immunocompromise. Diagnosis is the most challenging aspect of dealing with Aspergillus infections. Histology and culture remain the diagnostic gold standards. However, culture is not sensitive and cannot distinguish between colonization and true infections, and an invasive biopsy is usually contraindicated in patients with a bleeding tendency. Other diagnostic methods, such as the galactomannan test, polymerase chain reaction (PCR)-based studies, and metagenomic next-generation sequencing, have been used in clinical settings. These laboratory tests combined with computed tomography and the evaluation of clinical risk factors would promote the early diagnosis and initiation of early antifungal therapy. In this review, we introduce the clinical implications, sensitivity, and specificity of these tests in diagnosing invasive Aspergillus infection. |